Voters in more than a dozen Ohio municipalities will decide on ballot measures to decriminalize marijuana next month.
INVESTOR PROFILE | Ionic Brands
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
52-Week
Range N/A
Range N/A
Current
Outstanding 108,436,715
Outstanding 108,436,715
Warrants
Options
Fully Diluted
Market Cap.
14,639,000
14,639,000
IONIC BRANDS (CSE: IONC) has a premium portfolio of cannabis concentrate consumer brands. Ionic Brands is one of the top selling concentrate company in Washington State.
Company Brief
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Highlights
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
In The News
Ionic Is Changing the Face of Cannabis and Creating a Social Revolution
It’s all in the URL: Ionic.social. “We believe our products are best when enjoyed in a social setting,” said co-founder Christian Struzan.
READ MORE
Marijuana Vaping Is The Most Explosive Growth Play In Marijuana Today
“Nobody smokes marijuana anymore, they vape it.” - New York Times That's not quite true. But it will be soon.
READ MORE
How To Invest In Marijuana Vaping
The marijuana vaporization products (or just "vape") market is set to explode in 2019.
READ MORE
Related Articles
Psychedelics Regulation and Commercialization: Insights and Updates
The Schedule I classification for psychedelic drugs needs to be changed. But to what -- and when? Psychedelic Stock Watch takes a broad look at that question.
Mydecine Completes Spin-Out of U.S. Cannabis Assets
Mydecine spins out the company's cannabis assets into a private subsidiary, to comply with with the regulatory requirements of both the NASDAQ and London Stock Exchange.
MINDCURE Announces Commencement of Trading on the OTCQX Best Market
MINDCURE announces its addition to the OTCQX Best Markets tier.
California Could Decriminalize Drug “Magic Mushrooms” as Early as Next Year
The seeds have been planted for another California law that could loosen restrictions on the use of recreational drugs in the United States.
New Frontier Data Predict Global Cannabis Sales to Hit $51 billion by 2025
A New Frontier Data report highlights how much the cannabis industry will grow in the next few years.